Top
  • Skip to primary navigation
  • Skip to main content
A large image of the EUPATI logo
A small image of the EUPATI logo

European Patients' Academy

DA | DE | EN | ES | FR | IT | NL | PL | RU
Accessibility help

Share:

  • Share
  • Tweet
  • Share
  • Email
  •  Home
  • What is EUPATI?
    • EUPATI 2012-2017 Executive Summary
    • Contributors of IMI-EUPATI
    • Supporters of EUPATI
    • Reliable Information
    • EUPATI Ethical Framework
    • EUPATI Code of Conduct
    • Creative Commons
    • Contact
  • Resources
    • What is the Toolbox?
    • EUPATI Course
      • EUPATI Training Course
      • Download the Course
    • EUPATI Guidances
      • Guidance for patient involvement in industry-led medicines R&D
        • Webinar: Guidance on Patient Involvement on Industry-led R&D
      • Guidance for patient involvement in HTA
      • Guidance for patient involvement in regulatory processes
      • Guidance for patient involvement in ethical review of clinical trials
    • EUPATI Publications
    • EUPATI Media Downloads
    • EUPATI Webinars
      • Webinar: Guidance on Patient Involvement in Ethical Review of Clinical Trials
      • Webinar: Guidance on Patient Involvement on Industry-led R&D
      • Webinar: Informed Consent for Vulnerable Populations
      • Webinar: Early collaboration – a recipe for solutions: drug development and treatment strategies may go hand in hand.
      • Webinar: Strengthening patient involvement in Health Technology Assessment (HTA)
      • Webinar: Enabling meaningful patient contribution to ethical review?
      • Webinar: Creating Trainings with the EUPATI Toolbox
      • Webinar: Revision of CIOMS ethical guidelines for biomedical research.
    • EUPATI Workshops
      • 2017 Workshop: All Aboard to a Better Health Future
      • 2016 Workshop: The interaction of patients, regulators and industry.
      • 2015 Workshop: EUPATI Taking off in your Country
      • 2014 Workshop: Reaching a Public Audience on Medicines Development
      • 2014 Workshop: Meaningful Patient Involvement in Industry-led Medicines R&D
      • 2013 Workshop: A vision for 2020
      • 2012 Workshop: EUPATI’s Strategic Approach
  • National Platforms
  • Glossary
  • Blog
  • EFOEUPATI
  • COVID-19
Registration has been disabled.

Website policy

  • Privacy and Cookies Policy
  • Website Accessibility Policy
  • Terms and Conditions
  • Contact

Subscribe

  • This field is for validation purposes and should be left unchanged.

Twitter updates

  • @eupatients 5 hours

    #EUPATI National Platforms (#ENPs) are active in 23 countries all around Europe - and also in Japan! Meeting of rep… twitter.com/i/web/status/1…

  • @eupatients 2020/11/23

    Join us at the last session of #PEOF2020 today! twitter.com/imi_paradigm/s…

European Union and Innovatiove Medicines Inititive and EFPIA logo

The EUPATI Programme receives resources and support from public institutions, NGOs, and EFPIA companies. It was established by the IMI-EUPATI project which received support from the European Union IMI JU and EFPIA companies.
Copyright EUPATI ©. EUPATI provides all of its content for free, non-commercial use under a Creative Commons CC BY-NC-SA 4.0 copyright license.


Diese Website verwendet eine begrenzte Anzahl an Cookies, um Ihr Navigationserlebnis zu verbessern. Für weitere Informationen lesen Sie bitte unsere Cookie-Richtlinie.

Indem sie „Akzeptieren“ anklicken oder diese Website weiter nutzen, bestätigen Sie, dass Sie unsere Cookie-Richtlinie zur Verwendung von Cookies gelesen und ihr zugestimmt haben.

Lesen Sie unsere Cookie-Richtlinie Akzeptieren

Privacy & Cookies Policy
Necessary Always Enabled